Novo Nordisk A/S | NOVOB - Cost Of Sales

Stock Price
295.50
Daily Change
14.85 5.29%
Monthly
-19.35%
Yearly
-53.01%
Q1 Forecast
351.07

Novo Nordisk reported DKK15.15B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Bausch Health Companies USD 750M 14M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pacira USD 48.6M 6.59M Sep/2025
Sanofi EUR 4.29B 421M Dec/2025
Supernus Pharmaceuticals USD 43.29M 5.64M Sep/2025